Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	719	602	966	1,030	1,147	1,498
Market Cap Growth	-20.12%	-37.67%	-6.21%	-10.15%	-23.45%	256.47%
Enterprise Value	763	518	986	1,227	1,324	1,530
Last Close Price	232.85	194.95	311.79	331.90	368.45	480.90

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	-	13.59	47.64	6.89	8.72
PS Ratio	0.24	0.21	0.34	0.37	0.37	0.68
PB Ratio	1.06	0.88	1.35	1.59	1.82	3.20
P/TBV Ratio	1.06	0.88	1.35	1.59	1.82	3.20
P/FCF Ratio	12.44	10.41	-	11.78	-	9.25
P/OCF Ratio	8.10	6.78	-	10.95	-	8.57

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.26	0.18	0.35	0.44	0.43	0.69
EV/EBITDA Ratio	-	-	9.47	48.85	5.51	6.28
EV/EBIT Ratio	-	-	10.11	65.76	5.66	6.43
EV/FCF Ratio	13.19	8.96	-	14.03	-	9.45

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.16	0.16	0.14	0.13	0.30	0.16
Debt / EBITDA Ratio	-	-	0.95	3.37	0.78	0.31
Debt / FCF Ratio	-	1.85	-	0.97	-	0.46
Net Debt / Equity Ratio	0.06	0.07	0.13	-0.02	0.11	-0.15
Net Debt / EBITDA Ratio	-3.18	-2.17	0.91	-0.49	0.28	-0.29
Net Debt / FCF Ratio	-	0.77	-0.90	-0.14	-0.62	-0.44
Asset Turnover	-	2.36	2.35	2.36	3.09	3.13
Inventory Turnover	-	6.94	9.09	10.16	12.37	15.95
Quick Ratio	-	1.03	1.15	1.40	1.20	1.56
Current Ratio	-	1.86	2.09	1.82	1.86	1.91
Return on Equity (ROE)	-	-4.73%	10.40%	3.38%	30.25%	44.95%
Return on Assets (ROA)	-	-1.41%	5.01%	0.98%	14.53%	20.93%
Return on Invested Capital (ROIC)	-2.90%	-3.60%	9.67%	2.40%	31.51%	45.83%
Return on Capital Employed (ROCE)	-	-4.00%	13.60%	2.90%	36.90%	50.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-3.07%	-5.50%	7.36%	2.10%	14.50%	11.47%
FCF Yield	8.04%	9.60%	-10.97%	8.49%	-9.50%	10.81%
Dividend Yield	0.43%	-	0.32%	0.30%	0.27%	0.21%
Payout Ratio	-	-	4.35%	14.29%	1.86%	-
Total Shareholder Return	0.55%	-	0.32%	0.30%	0.27%	0.21%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error